Interestingly, a DNA vaccine encoding the HPV16 oncoproteins, E5, E6, and E7 genetically fused to Herpes simplex virus type 1 HSV-1 glycoprotein D conferred CD8+ T cell protective responses and anti-tumour effects in immunized mice [232]. This evidence concerns the gene CD8A and neoplasm.